img

Global Anti-Inflammatory Peptides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-Inflammatory Peptides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal\'s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases.
Anti-Inflammatory Peptides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Inflammatory Peptides market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Use and Clinic Use are the major drivers for the industry.
North America has dominated the entire market in 2014, as it has presence of technologically updated systems, strong research & development, and high patient awareness levels in this region. Latin America is also expected to grow at a healthy rate as a result of increase in both private and public associations, causing an increase in the investment, thereby boosting the demand for the anti-inflammatory peptides. However, the Asia Pacific region is expected to witness lucrative growth during the forecast period owing to the rapidly improving healthcare infrastructure in the growing economies of India and China. Growing patient awareness levels among the population of this region coupled with high unmet needs of the patients is expected to further drive this region.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Inflammatory Peptides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Mylan Pharmaceuticals
Novartis AG
Rogne Bioscience
Merck Serono
F4 Pharma
Araim Pharmaceuticals, Inc.
Digna Biotech
Abbvie Corporation
Segment by Type
Cardiovascular Diseases
Gastrointestinal Diseases
Dermatological Diseases
Neurological Diseases
Otorhino Diseases & Ophthalmological
Respiratory Diseases & Pulmonary
Renal Diseases
Rheumatological & Autoimmune Diseases
Transplantation

Segment by Application


Hospital Use
Clinic Use
Household
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Anti-Inflammatory Peptides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Inflammatory Peptides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Inflammatory Peptides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anti-Inflammatory Peptides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Inflammatory Peptides introduction, etc. Anti-Inflammatory Peptides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Anti-Inflammatory Peptides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Anti-Inflammatory Peptides Market Overview
1.1 Anti-Inflammatory Peptides Product Overview
1.2 Anti-Inflammatory Peptides Market Segment by Type
1.2.1 Cardiovascular Diseases
1.2.2 Gastrointestinal Diseases
1.2.3 Dermatological Diseases
1.2.4 Neurological Diseases
1.2.5 Otorhino Diseases & Ophthalmological
1.2.6 Respiratory Diseases & Pulmonary
1.2.7 Renal Diseases
1.2.8 Rheumatological & Autoimmune Diseases
1.2.9 Transplantation
1.3 Global Anti-Inflammatory Peptides Market Size by Type
1.3.1 Global Anti-Inflammatory Peptides Market Size Overview by Type (2018-2034)
1.3.2 Global Anti-Inflammatory Peptides Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-Inflammatory Peptides Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Inflammatory Peptides Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-Inflammatory Peptides Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-Inflammatory Peptides Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-Inflammatory Peptides Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-Inflammatory Peptides Sales Breakdown by Type (2018-2024)
2 Global Anti-Inflammatory Peptides Market Competition by Company
2.1 Global Top Players by Anti-Inflammatory Peptides Sales (2018-2024)
2.2 Global Top Players by Anti-Inflammatory Peptides Revenue (2018-2024)
2.3 Global Top Players by Anti-Inflammatory Peptides Price (2018-2024)
2.4 Global Top Manufacturers Anti-Inflammatory Peptides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Inflammatory Peptides Market Competitive Situation and Trends
2.5.1 Anti-Inflammatory Peptides Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Inflammatory Peptides Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Inflammatory Peptides as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Inflammatory Peptides Market
2.8 Key Manufacturers Anti-Inflammatory Peptides Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Inflammatory Peptides Status and Outlook by Region
3.1 Global Anti-Inflammatory Peptides Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anti-Inflammatory Peptides Historic Market Size by Region
3.2.1 Global Anti-Inflammatory Peptides Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-Inflammatory Peptides Sales in Value by Region (2018-2024)
3.2.3 Global Anti-Inflammatory Peptides Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-Inflammatory Peptides Forecasted Market Size by Region
3.3.1 Global Anti-Inflammatory Peptides Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-Inflammatory Peptides Sales in Value by Region (2024-2034)
3.3.3 Global Anti-Inflammatory Peptides Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-Inflammatory Peptides by Application
4.1 Anti-Inflammatory Peptides Market Segment by Application
4.1.1 Hospital Use
4.1.2 Clinic Use
4.1.3 Household
4.1.4 Other
4.2 Global Anti-Inflammatory Peptides Market Size by Application
4.2.1 Global Anti-Inflammatory Peptides Market Size Overview by Application (2018-2034)
4.2.2 Global Anti-Inflammatory Peptides Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti-Inflammatory Peptides Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Inflammatory Peptides Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti-Inflammatory Peptides Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti-Inflammatory Peptides Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti-Inflammatory Peptides Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti-Inflammatory Peptides Sales Breakdown by Application (2018-2024)
5 North America Anti-Inflammatory Peptides by Country
5.1 North America Anti-Inflammatory Peptides Historic Market Size by Country
5.1.1 North America Anti-Inflammatory Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anti-Inflammatory Peptides Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-Inflammatory Peptides Sales in Value by Country (2018-2024)
5.2 North America Anti-Inflammatory Peptides Forecasted Market Size by Country
5.2.1 North America Anti-Inflammatory Peptides Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-Inflammatory Peptides Sales in Value by Country (2024-2034)
6 Europe Anti-Inflammatory Peptides by Country
6.1 Europe Anti-Inflammatory Peptides Historic Market Size by Country
6.1.1 Europe Anti-Inflammatory Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anti-Inflammatory Peptides Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-Inflammatory Peptides Sales in Value by Country (2018-2024)
6.2 Europe Anti-Inflammatory Peptides Forecasted Market Size by Country
6.2.1 Europe Anti-Inflammatory Peptides Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-Inflammatory Peptides Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-Inflammatory Peptides by Region
7.1 Asia-Pacific Anti-Inflammatory Peptides Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Inflammatory Peptides Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-Inflammatory Peptides Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-Inflammatory Peptides Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-Inflammatory Peptides Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Inflammatory Peptides Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-Inflammatory Peptides Sales in Value by Region (2024-2034)
8 Latin America Anti-Inflammatory Peptides by Country
8.1 Latin America Anti-Inflammatory Peptides Historic Market Size by Country
8.1.1 Latin America Anti-Inflammatory Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anti-Inflammatory Peptides Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-Inflammatory Peptides Sales in Value by Country (2018-2024)
8.2 Latin America Anti-Inflammatory Peptides Forecasted Market Size by Country
8.2.1 Latin America Anti-Inflammatory Peptides Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-Inflammatory Peptides Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-Inflammatory Peptides by Country
9.1 Middle East and Africa Anti-Inflammatory Peptides Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Inflammatory Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-Inflammatory Peptides Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-Inflammatory Peptides Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-Inflammatory Peptides Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Inflammatory Peptides Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-Inflammatory Peptides Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Mylan Pharmaceuticals
10.1.1 Mylan Pharmaceuticals Company Information
10.1.2 Mylan Pharmaceuticals Introduction and Business Overview
10.1.3 Mylan Pharmaceuticals Anti-Inflammatory Peptides Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Mylan Pharmaceuticals Anti-Inflammatory Peptides Products Offered
10.1.5 Mylan Pharmaceuticals Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Anti-Inflammatory Peptides Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis AG Anti-Inflammatory Peptides Products Offered
10.2.5 Novartis AG Recent Development
10.3 Rogne Bioscience
10.3.1 Rogne Bioscience Company Information
10.3.2 Rogne Bioscience Introduction and Business Overview
10.3.3 Rogne Bioscience Anti-Inflammatory Peptides Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Rogne Bioscience Anti-Inflammatory Peptides Products Offered
10.3.5 Rogne Bioscience Recent Development
10.4 Merck Serono
10.4.1 Merck Serono Company Information
10.4.2 Merck Serono Introduction and Business Overview
10.4.3 Merck Serono Anti-Inflammatory Peptides Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Serono Anti-Inflammatory Peptides Products Offered
10.4.5 Merck Serono Recent Development
10.5 F4 Pharma
10.5.1 F4 Pharma Company Information
10.5.2 F4 Pharma Introduction and Business Overview
10.5.3 F4 Pharma Anti-Inflammatory Peptides Sales, Revenue and Gross Margin (2018-2024)
10.5.4 F4 Pharma Anti-Inflammatory Peptides Products Offered
10.5.5 F4 Pharma Recent Development
10.6 Araim Pharmaceuticals, Inc.
10.6.1 Araim Pharmaceuticals, Inc. Company Information
10.6.2 Araim Pharmaceuticals, Inc. Introduction and Business Overview
10.6.3 Araim Pharmaceuticals, Inc. Anti-Inflammatory Peptides Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Araim Pharmaceuticals, Inc. Anti-Inflammatory Peptides Products Offered
10.6.5 Araim Pharmaceuticals, Inc. Recent Development
10.7 Digna Biotech
10.7.1 Digna Biotech Company Information
10.7.2 Digna Biotech Introduction and Business Overview
10.7.3 Digna Biotech Anti-Inflammatory Peptides Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Digna Biotech Anti-Inflammatory Peptides Products Offered
10.7.5 Digna Biotech Recent Development
10.8 Abbvie Corporation
10.8.1 Abbvie Corporation Company Information
10.8.2 Abbvie Corporation Introduction and Business Overview
10.8.3 Abbvie Corporation Anti-Inflammatory Peptides Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Abbvie Corporation Anti-Inflammatory Peptides Products Offered
10.8.5 Abbvie Corporation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Inflammatory Peptides Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Inflammatory Peptides Industrial Chain Analysis
11.4 Anti-Inflammatory Peptides Market Dynamics
11.4.1 Anti-Inflammatory Peptides Industry Trends
11.4.2 Anti-Inflammatory Peptides Market Drivers
11.4.3 Anti-Inflammatory Peptides Market Challenges
11.4.4 Anti-Inflammatory Peptides Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Inflammatory Peptides Distributors
12.3 Anti-Inflammatory Peptides Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Cardiovascular Diseases
Table 2. Major Company of Gastrointestinal Diseases
Table 3. Major Company of Dermatological Diseases
Table 4. Major Company of Neurological Diseases
Table 5. Major Company of Otorhino Diseases & Ophthalmological
Table 6. Major Company of Respiratory Diseases & Pulmonary
Table 7. Major Company of Renal Diseases
Table 8. Major Company of Rheumatological & Autoimmune Diseases
Table 9. Major Company of Transplantation
Table 10. Global Anti-Inflammatory Peptides Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Anti-Inflammatory Peptides Sales by Type (2018-2024) & (K Units)
Table 12. Global Anti-Inflammatory Peptides Sales Market Share in Volume by Type (2018-2024)
Table 13. Global Anti-Inflammatory Peptides Sales by Type (2018-2024) & (US& Million)
Table 14. Global Anti-Inflammatory Peptides Market Share in Value by Type (2018-2024)
Table 15. Global Anti-Inflammatory Peptides Price by Type (2018-2024) & (USD/Unit)
Table 16. Global Anti-Inflammatory Peptides Sales by Type (2024-2034) & (K Units)
Table 17. Global Anti-Inflammatory Peptides Sales Market Share in Volume by Type (2024-2034)
Table 18. Global Anti-Inflammatory Peptides Sales by Type (2024-2034) & (US$ Million)
Table 19. Global Anti-Inflammatory Peptides Sales Market Share in Value by Type (2024-2034)
Table 20. Global Anti-Inflammatory Peptides Price by Type (2024-2034) & (USD/Unit)
Table 21. North America Anti-Inflammatory Peptides Sales by Type (2018-2024) & (K Units)
Table 22. North America Anti-Inflammatory Peptides Sales by Type (2018-2024) & (US$ Million)
Table 23. Europe Anti-Inflammatory Peptides Sales (K Units) by Type (2018-2024)
Table 24. Europe Anti-Inflammatory Peptides Sales by Type (2018-2024) & (US$ Million)
Table 25. Asia-Pacific Anti-Inflammatory Peptides Sales (K Units) by Type (2018-2024)
Table 26. Asia-Pacific Anti-Inflammatory Peptides Sales by Type (2018-2024) & (US$ Million)
Table 27. Latin America Anti-Inflammatory Peptides Sales (K Units) by Type (2018-2024)
Table 28. Latin America Anti-Inflammatory Peptides Sales by Type (2018-2024) & (US$ Million)
Table 29. Middle East and Africa Anti-Inflammatory Peptides Sales (K Units) by Type (2018-2024)
Table 30. Middle East and Africa Anti-Inflammatory Peptides Sales by Type (2018-2024) & (US$ Million)
Table 31. Global Anti-Inflammatory Peptides Sales by Company (2018-2024) & (K Units)
Table 32. Global Anti-Inflammatory Peptides Sales Share by Company (2018-2024)
Table 33. Global Anti-Inflammatory Peptides Revenue by Company (2018-2024) & (US$ Million)
Table 34. Global Anti-Inflammatory Peptides Revenue Share by Company (2018-2024)
Table 35. Global Market Anti-Inflammatory Peptides Price by Company (2018-2024) & (USD/Unit)
Table 36. Global Anti-Inflammatory Peptides Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 37. Global Anti-Inflammatory Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 38. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Inflammatory Peptides as of 2022)
Table 39. Date of Key Manufacturers Enter into Anti-Inflammatory Peptides Market
Table 40. Key Manufacturers Anti-Inflammatory Peptides Product Type
Table 41. Mergers & Acquisitions, Expansion Plans
Table 42. Global Anti-Inflammatory Peptides Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 43. Global Anti-Inflammatory Peptides Sales by Region (2018-2024) & (K Units)
Table 44. Global Anti-Inflammatory Peptides Sales Market Share in Volume by Region (2018-2024)
Table 45. Global Anti-Inflammatory Peptides Sales by Region (2018-2024) & (US$ Million)
Table 46. Global Anti-Inflammatory Peptides Sales Market Share in Value by Region (2018-2024)
Table 47. Global Anti-Inflammatory Peptides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 48. Global Anti-Inflammatory Peptides Sales by Region (2024-2034) & (K Units)
Table 49. Global Anti-Inflammatory Peptides Sales Market Share in Volume by Region (2024-2034)
Table 50. Global Anti-Inflammatory Peptides Sales by Region (2024-2034) & (US$ Million)
Table 51. Global Anti-Inflammatory Peptides Sales Market Share in Value by Region (2024-2034)
Table 52. Global Anti-Inflammatory Peptides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 53. Global Anti-Inflammatory Peptides Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 54. Global Anti-Inflammatory Peptides Sales by Application (2018-2024) & (K Units)
Table 55. Global Anti-Inflammatory Peptides Sales Market Share in Volume by Application (2018-2024)
Table 56. Global Anti-Inflammatory Peptides Sales by Application (2018-2024) & (US$ Million)
Table 57. Global Anti-Inflammatory Peptides Sales Market Share in Value by Application (2018-2024)
Table 58. Global Anti-Inflammatory Peptides Price by Application (2018-2024) & (USD/Unit)
Table 59. Global Anti-Inflammatory Peptides Sales by Application (2024-2034) & (K Units)
Table 60. Global Anti-Inflammatory Peptides Sales Market Share in Volume by Application (2024-2034)
Table 61. Global Anti-Inflammatory Peptides Sales by Application (2024-2034) & (US$ Million)
Table 62. Global Anti-Inflammatory Peptides Sales Market Share in Value by Application (2024-2034)
Table 63. Global Anti-Inflammatory Peptides Price by Application (2024-2034) & (USD/Unit)
Table 64. North America Anti-Inflammatory Peptides Sales by Application (2018-2024) (K Units)
Table 65. North America Anti-Inflammatory Peptides Sales by Application (2018-2024) & (US$ Million)
Table 66. Europe Anti-Inflammatory Peptides Sales by Application (2018-2024) (K Units)
Table 67. Europe Anti-Inflammatory Peptides Sales by Application (2018-2024) & (US$ Million)
Table 68. Asia-Pacific Anti-Inflammatory Peptides Sales by Application (2018-2024) (K Units)
Table 69. Asia-Pacific Anti-Inflammatory Peptides Sales by Application (2018-2024) & (US$ Million)
Table 70. Latin America Anti-Inflammatory Peptides Sales by Application (2018-2024) (K Units)
Table 71. Latin America Anti-Inflammatory Peptides Sales by Application (2018-2024) & (US$ Million)
Table 72. Middle East and Africa Anti-Inflammatory Peptides Sales by Application (2018-2024) (K Units)
Table 73. Middle East and Africa Anti-Inflammatory Peptides Sales by Application (2018-2024) & (US$ Million)
Table 74. North America Anti-Inflammatory Peptides Sales by Country (2018-2024) & (K Units)
Table 75. North America Anti-Inflammatory Peptides Sales Market Share in Volume by Country (2018-2024)
Table 76. North America Anti-Inflammatory Peptides Sales by Country (2018-2024) & (US$ Million)
Table 77. North America Anti-Inflammatory Peptides Sales Market Share in Value by Country (2018-2024)
Table 78. North America Anti-Inflammatory Peptides Sales by Country (2024-2034) & (K Units)
Table 79. North America Anti-Inflammatory Peptides Sales Market Share in Volume by Country (2024-2034)
Table 80. North America Anti-Inflammatory Peptides Sales by Country (2024-2034) & (US$ Million)
Table 81. North America Anti-Inflammatory Peptides Sales Market Share in Value by Country (2024-2034)
Table 82. Europe Anti-Inflammatory Peptides Sales by Country (2018-2024) & (K Units)
Table 83. Europe Anti-Inflammatory Peptides Sales Market Share in Volume by Country (2018-2024)
Table 84. Europe Anti-Inflammatory Peptides Sales by Country (2018-2024) & (US$ Million)
Table 85. Europe Anti-Inflammatory Peptides Sales Market Share in Value by Country (2018-2024)
Table 86. Europe Anti-Inflammatory Peptides Sales by Country (2024-2034) & (K Units)
Table 87. Europe Anti-Inflammatory Peptides Sales Market Share in Volume by Country (2024-2034)
Table 88. Europe Anti-Inflammatory Peptides Sales by Country (2024-2034) & (US$ Million)
Table 89. Europe Anti-Inflammatory Peptides Sales Market Share in Value by Country (2024-2034)
Table 90. Asia-Pacific Anti-Inflammatory Peptides Sales by Region (2018-2024) & (K Units)
Table 91. Asia-Pacific Anti-Inflammatory Peptides Sales Market Share in Volume by Region (2018-2024)
Table 92. Asia-Pacific Anti-Inflammatory Peptides Sales by Region (2018-2024) & (US$ Million)
Table 93. Asia-Pacific Anti-Inflammatory Peptides Sales Market Share in Value by Region (2018-2024)
Table 94. Asia-Pacific Anti-Inflammatory Peptides Sales by Region (2024-2034) & (K Units)
Table 95. Asia-Pacific Anti-Inflammatory Peptides Sales Market Share in Volume by Region (2024-2034)
Table 96. Asia-Pacific Anti-Inflammatory Peptides Sales by Region (2024-2034) & (US$ Million)
Table 97. Asia-Pacific Anti-Inflammatory Peptides Sales Market Share in Value by Region (2024-2034)
Table 98. Latin America Anti-Inflammatory Peptides Sales by Country (2018-2024) & (K Units)
Table 99. Latin America Anti-Inflammatory Peptides Sales Market Share in Volume by Country (2018-2024)
Table 100. Latin America Anti-Inflammatory Peptides Sales by Country (2018-2024) & (US$ Million)
Table 101. Latin America Anti-Inflammatory Peptides Sales Market Share in Value by Country (2018-2024)
Table 102. Latin America Anti-Inflammatory Peptides Sales by Country (2024-2034) & (K Units)
Table 103. Latin America Anti-Inflammatory Peptides Sales Market Share in Volume by Country (2024-2034)
Table 104. Latin America Anti-Inflammatory Peptides Sales by Country (2024-2034) & (US$ Million)
Table 105. Latin America Anti-Inflammatory Peptides Sales Market Share in Value by Country (2024-2034)
Table 106. Middle East and Africa Anti-Inflammatory Peptides Sales by Country (2018-2024) & (K Units)
Table 107. Middle East and Africa Anti-Inflammatory Peptides Sales Market Share in Volume by Country (2018-2024)
Table 108. Middle East and Africa Anti-Inflammatory Peptides Sales by Country (2018-2024) & (US$ Million)
Table 109. Middle East and Africa Anti-Inflammatory Peptides Sales Market Share in Value by Country (2018-2024)
Table 110. Middle East and Africa Anti-Inflammatory Peptides Sales by Country (2024-2034) & (K Units)
Table 111. Middle East and Africa Anti-Inflammatory Peptides Sales Market Share in Volume by Country (2024-2034)
Table 112. Middle East and Africa Anti-Inflammatory Peptides Sales by Country (2024-2034) & (US$ Million)
Table 113. Middle East and Africa Anti-Inflammatory Peptides Sales Market Share in Value by Country (2024-2034)
Table 114. Mylan Pharmaceuticals Company Information
Table 115. Mylan Pharmaceuticals Introduction and Business Overview
Table 116. Mylan Pharmaceuticals Anti-Inflammatory Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Mylan Pharmaceuticals Anti-Inflammatory Peptides Product
Table 118. Mylan Pharmaceuticals Recent Development
Table 119. Novartis AG Company Information
Table 120. Novartis AG Introduction and Business Overview
Table 121. Novartis AG Anti-Inflammatory Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Novartis AG Anti-Inflammatory Peptides Product
Table 123. Novartis AG Recent Development
Table 124. Rogne Bioscience Company Information
Table 125. Rogne Bioscience Introduction and Business Overview
Table 126. Rogne Bioscience Anti-Inflammatory Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Rogne Bioscience Anti-Inflammatory Peptides Product
Table 128. Rogne Bioscience Recent Development
Table 129. Merck Serono Company Information
Table 130. Merck Serono Introduction and Business Overview
Table 131. Merck Serono Anti-Inflammatory Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Merck Serono Anti-Inflammatory Peptides Product
Table 133. Merck Serono Recent Development
Table 134. F4 Pharma Company Information
Table 135. F4 Pharma Introduction and Business Overview
Table 136. F4 Pharma Anti-Inflammatory Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. F4 Pharma Anti-Inflammatory Peptides Product
Table 138. F4 Pharma Recent Development
Table 139. Araim Pharmaceuticals, Inc. Company Information
Table 140. Araim Pharmaceuticals, Inc. Introduction and Business Overview
Table 141. Araim Pharmaceuticals, Inc. Anti-Inflammatory Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Araim Pharmaceuticals, Inc. Anti-Inflammatory Peptides Product
Table 143. Araim Pharmaceuticals, Inc. Recent Development
Table 144. Digna Biotech Company Information
Table 145. Digna Biotech Introduction and Business Overview
Table 146. Digna Biotech Anti-Inflammatory Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Digna Biotech Anti-Inflammatory Peptides Product
Table 148. Digna Biotech Recent Development
Table 149. Abbvie Corporation Company Information
Table 150. Abbvie Corporation Introduction and Business Overview
Table 151. Abbvie Corporation Anti-Inflammatory Peptides Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Abbvie Corporation Anti-Inflammatory Peptides Product
Table 153. Abbvie Corporation Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Anti-Inflammatory Peptides Market Trends
Table 157. Anti-Inflammatory Peptides Market Drivers
Table 158. Anti-Inflammatory Peptides Market Challenges
Table 159. Anti-Inflammatory Peptides Market Restraints
Table 160. Anti-Inflammatory Peptides Distributors List
Table 161. Anti-Inflammatory Peptides Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Inflammatory Peptides Product Picture
Figure 2. Global Anti-Inflammatory Peptides Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-Inflammatory Peptides Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anti-Inflammatory Peptides Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Cardiovascular Diseases
Figure 6. Global Cardiovascular Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Gastrointestinal Diseases
Figure 8. Global Gastrointestinal Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Dermatological Diseases
Figure 10. Global Dermatological Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Neurological Diseases
Figure 12. Global Neurological Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Otorhino Diseases & Ophthalmological
Figure 14. Global Otorhino Diseases & Ophthalmological Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Respiratory Diseases & Pulmonary
Figure 16. Global Respiratory Diseases & Pulmonary Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Product Picture of Renal Diseases
Figure 18. Global Renal Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 19. Product Picture of Rheumatological & Autoimmune Diseases
Figure 20. Global Rheumatological & Autoimmune Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 21. Product Picture of Transplantation
Figure 22. Global Transplantation Sales YoY Growth (2018-2034) & (K Units)
Figure 23. Global Anti-Inflammatory Peptides Sales by Type (2018-2034) & (US$ Million)
Figure 24. Global Anti-Inflammatory Peptides Sales Market Share by Type in 2022 & 2034
Figure 25. North America Anti-Inflammatory Peptides Sales Market Share in Volume by Type in 2022
Figure 26. North America Anti-Inflammatory Peptides Sales Market Share in Value by Type in 2022
Figure 27. Europe Anti-Inflammatory Peptides Sales Market Share in Volume by Type in 2022
Figure 28. Europe Anti-Inflammatory Peptides Sales Market Share in Value by Type in 2022
Figure 29. Asia-Pacific Anti-Inflammatory Peptides Sales Market Share in Volume by Type in 2022
Figure 30. Asia-Pacific Anti-Inflammatory Peptides Sales Market Share in Value by Type in 2022
Figure 31. Latin America Anti-Inflammatory Peptides Sales Market Share in Volume by Type in 2022
Figure 32. Latin America Anti-Inflammatory Peptides Sales Market Share in Value by Type in 2022
Figure 33. Middle East and Africa Anti-Inflammatory Peptides Sales Market Share in Volume by Type in 2022
Figure 34. Middle East and Africa Anti-Inflammatory Peptides Sales Market Share in Value by Type in 2022
Figure 35. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Inflammatory Peptides Sales in 2022
Figure 36. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Inflammatory Peptides Revenue in 2022
Figure 37. Anti-Inflammatory Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 38. Product Picture of Hospital Use
Figure 39. Global Hospital Use Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of Clinic Use
Figure 41. Global Clinic Use Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Product Picture of Household
Figure 43. Global Household Sales YoY Growth (2018-2034) & (K Units)
Figure 44. Product Picture of Other
Figure 45. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 46. Global Anti-Inflammatory Peptides Sales by Application (2018-2034) & (US$ Million)
Figure 47. Global Anti-Inflammatory Peptides Sales Market Share by Application in 2022 & 2034
Figure 48. North America Anti-Inflammatory Peptides Sales Market Share in Volume by Application in 2022
Figure 49. North America Anti-Inflammatory Peptides Sales Market Share in Value by Application in 2022
Figure 50. Europe Anti-Inflammatory Peptides Sales Market Share in Volume by Application in 2022
Figure 51. Europe Anti-Inflammatory Peptides Sales Market Share in Value by Application in 2022
Figure 52. Asia-Pacific Anti-Inflammatory Peptides Sales Market Share in Volume by Application in 2022
Figure 53. Asia-Pacific Anti-Inflammatory Peptides Sales Market Share in Value by Application in 2022
Figure 54. Latin America Anti-Inflammatory Peptides Sales Market Share in Volume by Application in 2022
Figure 55. Latin America Anti-Inflammatory Peptides Sales Market Share in Value by Application in 2022
Figure 56. Middle East and Africa Anti-Inflammatory Peptides Sales Market Share in Value by Application in 2022
Figure 57. Key Raw Materials Price
Figure 58. Anti-Inflammatory Peptides Manufacturing Cost Structure
Figure 59. Anti-Inflammatory Peptides Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries